HALO Halozyme Therapeutics PE ratio, current and historical analysis
As of Nov 21, 2024, the HALO stock has a P/E ratio of 14.89. The calculation is based on the latest EPS of $3.07 and the stock price of $45.7 per share. A decrease of 18% has been observed in the PE ratio compared to its average of 18.2 of the past four quarters.
HALO PE ratio history
The mean historical PE ratio of Halozyme Therapeutics over the last seven years is 32.3. The current 14.89 price-to-earnings ratio is 54% less than the historical average. Analyzing the last seven years, HALO's PE ratio reached its highest point in the Sep 2020 quarter at 146, with a price of $26.28 and an EPS of $0.18. The Mar 2022 quarter saw the lowest point at 12.95, with a price of $39.88 and an EPS of $3.08.
Halozyme Therapeutics PE ratio by year
Maximum annual increase: 173.47% in 2022
Maximum annual decrease: -68.73% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 17.35 | -54.88% |
| 2022 | 38.45 | 173.47% |
| 2021 | 14.06 | -68.73% |
| 2020 | 44.96 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | 44.04 | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
HALO average PE ratio chart
The current PE ratio of HALO is under its 3, 5 and 10-year averages.
HALO PE vs peers
HALO's PE ratio is below its peer stocks LLY and JNJ. Halozyme Therapeutics's current PE ratio of 14.89 is less than the average of its peers, which is 56.46.
| Stock name | PE ratio | Market cap |
|---|---|---|
| HALO Halozyme Therapeutics Inc | 14.89 | $5.81B |
| JNJ Johnson & Johnson | 25.79 | $374.39B |
| PFE Pfizer Inc | 33.07 | $142.41B |
| LLY ELI LILLY & Co | 80.72 | $711.91B |
| MNKD Mannkind Corp | 86.25 | $1.9B |
| BAX Baxter International Inc | 157.1 | $16.84B |
Frequently asked questions
What is Halozyme Therapeutics's PE ratio?
As of Nov 21, 2024, HALO stock has a price to earnings ratio of 14.89.
What is the 3-year average PE ratio for Halozyme Therapeutics (HALO)?
Over the last 3 years, the average PE ratio for HALO stock is 20.87.
What is the 5-year average PE ratio for Halozyme Therapeutics (HALO)?
Over the last 5 years, the average PE ratio for HALO stock is 30.45.
What is the highest PE ratio for HALO?
Over the last seven years, the quarterly PE ratio reached its highest level at 146 in the Sep 2020 quarter.
How does the current PE ratio for HALO compare to its historical average?
HALO's current price to earnings ratio is 54% below its 7-year historical average.
How is HALO's PE ratio calculated (Halozyme Therapeutics PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Nov 21, 2024), Halozyme Therapeutics's share price is $45.7. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $3.07. Therefore, Halozyme Therapeutics's price to earnings ratio for today is 14.89. PE RATIO(14.89) = STOCK PRICE($45.7) / TTM EPS($3.07)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.